US Stock MarketDetailed Quotes

ACIU AC Immune

Watchlist
  • 1.980
  • -0.140-6.60%
Close Mar 25 16:00 ET
  • 1.980
  • 0.0000.00%
Post 16:05 ET
198.81MMarket Cap-3.43P/E (TTM)

About AC Immune Company

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.

Company Profile

SymbolACIU
Company NameAC Immune
Listing DateSep 23, 2016
Issue Price11.00
Founded2003
CEODr. Andrea Pfeifer, PhD
MarketNASDAQ
Employees161
Fiscal Year Ends12-31
AddressEPFL Innovation Park,Building B
CityLausanne
ProvinceVaud
CountrySwitzerland
Zip Code1015
Phone41-21-345-91-21
Websitehttp://www.acimmune.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Andrea Pfeifer, PhD
  • Chief Executive Officer and Director
  • --
  • Dr. Anke Post, M.D.
  • Chief Medical Officer
  • --
  • Christopher Roberts
  • Chief Financial Officer
  • --
  • Piergiorgio Donati
  • Chief Technical Operations Officer
  • --
  • Howard Donovan
  • Chief Human Resources Officer
  • --
  • Dr. Bojana Portmann, PhD
  • Vice President, IP and Business Development
  • --
  • Dr. Matthias Maurer, PhD
  • Senior Vice President and General Counsel
  • --
  • Mark Danton
  • Executive Vice President, Information Systems and Artificial Intelligence
  • --
  • Dr. Julien Rongere, PhD
  • Senior Vice President, Regulatory Affairs and Quality Assurance
  • --
  • Dr. Olivier Sol, M.D.
  • Vice President and Head of Clinical Development
  • --
  • Dr. Gunther Staffler, PhD
  • Senior Vice President, Immunotherapy
  • --
  • Dr. Gary Waanders, PhD
  • Senior Vice President, Investor Relations and Corporate Communications
  • --
  • Dr. Francesca Capotosti, PhD
  • Vice President, Research
  • --
  • Professor Dr. Monika Butler, PhD
  • Vice Chairman of the Board
  • --
  • Dr. Douglas E. WilliaPhD
  • Chairman of the Board
  • --
  • Dr. Werner Lanthaler, PhD
  • Independent Director
  • --
  • Dr. Roy Twyman, M.D.
  • Independent Director
  • --
  • Professor Dr. Carl June, M.D.
  • Independent Director
  • --
  • Dr. Monica Shaw, M.D.
  • Independent Director
  • --
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Enerpac Tool
EPAC
+8.39%
Precision Drilling
PDS
+2.04%
Halozyme Therapeutics
HALO
+1.28%
Workday
WDAY
+1.17%
Lantheus
LNTH
+0.33%

Unlock the Full List